AI

Neurable Licenses Its Non-Invasive BCI to Wearable Makers

Neurable will license its non-invasive EEG brain-computer interface to wearable makers, with AI reading brain signals to gauge focus. The HyperX deal and the privacy line.

Neurable Licenses Its Non-Invasive BCI to Wearable Makers — article cover

On April 28, 2026, TechCrunch reported that Neurable, a brain-computer interface (BCI) startup, will license its non-invasive “mind-reading” technology to consumer electronics makers. The stack: EEG sensors plus signal processing to scan brain activity, with AI analyzing those signals to assess cognitive performance. OEMs can embed the whole package into headphones, hats, glasses, and headbands — while keeping full control over product design, user experience, and distribution.

The timing matters. Neurable closed a $35 million Series A in December 2025 (covered by MobiHealthNews) explicitly to scale commercialization, and this licensing announcement is the roadmap for that money: rather than building its own consumer devices, the company wants to become the standard component supplier inside everyone else’s wearables.

A Brain-Computer Interface Without Surgery

Say “BCI” and most people picture Neuralink: skull surgery, implanted chips, human trials — a track that investors have backed seriously, with Neuralink closing a $650 million Series E in June 2025. Neurable takes the other road — non-invasive, reading brainwaves through scalp-level EEG sensors, with signal processing and AI models doing the interpretation. The precision is no match for implanted electrodes, but zero surgical risk, all-day wearability, and mass manufacturability are exactly the properties that matter to consumer electronics companies. They are what could turn neural monitoring into “a heart-rate strap for your head.”

The Licensing Model: Neural Sensing as a Component

CEO Ramses Alcaide states the goal in one line: “let’s make this as ubiquitous as heart rate sensors on your wrist.” He describes the industry as at an inflection point, with “a real business model in neuro-technology that is scalable” for the first time.

The play is component licensing. The target categories are health and athletic products, productivity tools, and gaming. The OEM owns the hardware and the brand; Neurable owns the sensing and AI interpretation layer. For device makers, this amounts to adding “cognitive state” as a new sensing dimension to a headphone or headband without standing up an in-house neuroscience team — the same way heart rate and blood oxygen were folded into wearables over the past decade.

It also spreads the risk. A component supplier does not have to guess which form factor wins — headphones, headbands, glasses, or hats — because it ships inside all of them. And every new OEM category that adopts the stack adds training signal and distribution without Neurable spending its own capital on retail. That is the structural argument for why licensing, rather than a first-party device, is the credible path to ubiquity for a neurotech company at this stage.

From Gaming Headsets to Human Behavior Research

Two deployments already exist. The first is HyperX, HP’s gaming brand: the jointly built brain-tracking gaming headset promises to help gamers “level up their game play by optimizing focus and performance,” and it earned top honors at CES 2026. The second is iMotions, a human behavior research software platform that has integrated the Neurable headset so academic teams can fold EEG data directly into behavioral experiments. Alcaide declined to name new partners, saying only that the company is expanding across multiple domains.

The Privacy Line for Neural Data

Brainwaves are a more sensitive signal than heartbeats, and the privacy question cannot be dodged. Neurable’s position: user data is encrypted and anonymized, the company follows HIPAA standards, and it has gone “above and beyond where a lot of startups would be at our stage.” Neural data is used to train AI only with user consent, tied to specific experiments — in Alcaide’s words, “We are not collecting the data, just training on it willy-nilly.”

How durable that commitment proves to be institutionally is an open question, but the direction is clear. As AI moves from the clinic and the lab into everyday health measurement — from Oxford’s CT heart-failure prediction to brainwave sensing on your head — data governance will decide whether a product can be trusted as much as the algorithm itself does. Heart-rate sensors took a decade to become ubiquitous; whether EEG sensing can repeat that path depends first on getting privacy engineering right.

Sources

AI-assisted summary compiled from the sources above, reviewed by a human before publishing.

FOUND_THIS_USEFUL?

Support more practical AI articles, tutorials, and build notes.

BUY_ME_A_COFFEE
SHAREXEMAIL